Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.

Elsby R, Smith V, Fox L, Stresser D, Butters C, Sharma P, Surry DD.

Xenobiotica. 2011 Sep;41(9):764-83. doi: 10.3109/00498254.2011.578761. Epub 2011 May 25.

PMID:
21612343
2.

The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.

Elsby R, Gillen M, Butters C, Imisson G, Sharma P, Smith V, Surry DD.

Drug Metab Dispos. 2011 Feb;39(2):275-82. doi: 10.1124/dmd.110.035881. Epub 2010 Nov 12.

PMID:
21075975
3.
4.

Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.

Surry DD, Meneses-Lorente G, Heavens R, Jack A, Evans DC.

Xenobiotica. 2000 May;30(5):441-56.

PMID:
10875679
5.

High throughput ribonuclease protection assay for the determination of CYP3A mRNA induction in cultured rat hepatocytes.

Surry DD, McAllister G, Meneses-Lorente G, Evans DC.

Xenobiotica. 1999 Aug;29(8):827-38.

PMID:
10553723

Supplemental Content

Loading ...
Support Center